House Energy and Commerce Committee passes bill outlining FDA procedures to withdraw a drug

To withdraw a drug from the market, the FDA will have to provide the drug sponsor with notice and an explanation as well as the opportunity to meet with the FDA, addressing increased scrutiny on the FDA’s accelerated approvals program.